Thomas Flaten
Stock Analyst at Lake Street
(0.66)
# 3,781
Out of 4,832 analysts
39
Total ratings
37.5%
Success rate
-13.42%
Average return
Main Sectors:
Stocks Rated by Thomas Flaten
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CSTL Castle Biosciences | Maintains: Buy | $40 → $35 | $16.51 | +111.99% | 6 | May 6, 2025 | |
| OCX OncoCyte | Initiates: Buy | $5 | $2.67 | +87.27% | 5 | Mar 28, 2025 | |
| OPTN OptiNose | Downgrades: Hold | $17 → $9 | $9.47 | -4.96% | 5 | Mar 20, 2025 | |
| CKPT Checkpoint Therapeutics | Downgrades: Hold | $7 → $4.1 | $4.16 | -1.44% | 5 | Mar 10, 2025 | |
| AQST Aquestive Therapeutics | Maintains: Buy | $10 → $8 | $2.18 | +267.82% | 2 | Mar 7, 2025 | |
| EVAX Evaxion Biotech | Maintains: Buy | $35 → $6 | $1.62 | +270.37% | 2 | Feb 4, 2025 | |
| PSNL Personalis | Maintains: Buy | $7 → $9 | $4.85 | +85.76% | 2 | Jan 8, 2025 | |
| DERM Journey Medical | Initiates: Buy | $9 | $6.29 | +43.20% | 1 | Sep 6, 2024 | |
| ASRT Assertio Holdings | Maintains: Buy | $4 → $3 | $0.62 | +382.78% | 3 | Mar 12, 2024 | |
| ACHV Achieve Life Sciences | Maintains: Buy | $19 → $11 | $2.42 | +354.55% | 3 | Mar 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $34 → $25 | $22.50 | +11.11% | 2 | Aug 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14,400 → $1,440 | $2.27 | +63,336.12% | 2 | Nov 17, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $14 → $8 | $4.16 | +92.31% | 1 | Jul 7, 2022 |
Castle Biosciences
May 6, 2025
Maintains: Buy
Price Target: $40 → $35
Current: $16.51
Upside: +111.99%
OncoCyte
Mar 28, 2025
Initiates: Buy
Price Target: $5
Current: $2.67
Upside: +87.27%
OptiNose
Mar 20, 2025
Downgrades: Hold
Price Target: $17 → $9
Current: $9.47
Upside: -4.96%
Checkpoint Therapeutics
Mar 10, 2025
Downgrades: Hold
Price Target: $7 → $4.1
Current: $4.16
Upside: -1.44%
Aquestive Therapeutics
Mar 7, 2025
Maintains: Buy
Price Target: $10 → $8
Current: $2.18
Upside: +267.82%
Evaxion Biotech
Feb 4, 2025
Maintains: Buy
Price Target: $35 → $6
Current: $1.62
Upside: +270.37%
Personalis
Jan 8, 2025
Maintains: Buy
Price Target: $7 → $9
Current: $4.85
Upside: +85.76%
Journey Medical
Sep 6, 2024
Initiates: Buy
Price Target: $9
Current: $6.29
Upside: +43.20%
Assertio Holdings
Mar 12, 2024
Maintains: Buy
Price Target: $4 → $3
Current: $0.62
Upside: +382.78%
Achieve Life Sciences
Mar 5, 2024
Maintains: Buy
Price Target: $19 → $11
Current: $2.42
Upside: +354.55%
Aug 9, 2023
Maintains: Buy
Price Target: $34 → $25
Current: $22.50
Upside: +11.11%
Nov 17, 2022
Maintains: Buy
Price Target: $14,400 → $1,440
Current: $2.27
Upside: +63,336.12%
Jul 7, 2022
Maintains: Buy
Price Target: $14 → $8
Current: $4.16
Upside: +92.31%